Modern neuroscience has revealed how transcranial magnetic stimulation therapy affects the brain's structure, chemistry, and function — knowledge that's transforming treatment approaches.
The Brain Regions Involved in Transcranial Magnetic Stimulation Therapy
Key brain areas implicated in transcranial magnetic stimulation therapy include:
- Amygdala: The brain's threat-detection center becomes hyperactive in transcranial magnetic stimulation therapy, triggering excessive fear and stress responses
- Prefrontal Cortex: Responsible for rational thinking and emotional regulation — its function is often impaired by transcranial magnetic stimulation therapy
- Hippocampus: Memory and context processing; chronic transcranial magnetic stimulation therapy can affect its volume and function
- HPA Axis: The stress hormone system that, when dysregulated, drives many physical symptoms of transcranial magnetic stimulation therapy
Neurochemistry of Transcranial Magnetic Stimulation Therapy
Transcranial Magnetic Stimulation Therapy involves imbalances or dysregulation of key neurotransmitters including serotonin, dopamine, norepinephrine, and GABA — all targets of current treatments.
How Treatment Changes the Brain
Both therapy and medication produce measurable changes in brain function in transcranial magnetic stimulation therapy. CBT, for example, has been shown to normalize amygdala reactivity.
Neuroplasticity and Transcranial Magnetic Stimulation Therapy
The brain retains its ability to change throughout life. This neuroplasticity means that with appropriate treatment and practice, the neural patterns underlying transcranial magnetic stimulation therapy can genuinely change.